Literature DB >> 1347501

[Acquired protein C deficiency in ulcerative colitis. The cause of thromboembolic complications].

S Korsten1, H E Reis.   

Abstract

Three patients with an acute exacerbation of ulcerative colitis (a 40-year-old and a 31-year-old man and a 30-year-old woman) developed a protein C deficiency (serum protein C activity between 32 and 48%). In the two men the protein C deficiency was diagnosed only after the onset of severe thromboembolic complications (cavernous sinus thrombosis; pulmonary embolism) during heparin treatment. But in the woman protein C activity was measured immediately after hospital admission (in the knowledge of the first two cases) even before heparin administration was started. All three patients received treatment with sulphasalazine (3 g daily) and fluocortolone (60 mg daily), as well as full heparinization (22,500-36,000 IU daily). Protein C activity returned to normal on remission of the ulcerative colitis (in one case only after subtotal colectomy). These case reports show that acquired protein C deficiency can be reversed by rigorous treatment of the underlying disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1347501     DOI: 10.1055/s-2008-1062328

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  3 in total

Review 1.  Haemostatic system in inflammatory bowel diseases: new players in gut inflammation.

Authors:  Franco Scaldaferri; Stefano Lancellotti; Marco Pizzoferrato; Raimondo De Cristofaro
Journal:  World J Gastroenterol       Date:  2011-02-07       Impact factor: 5.742

2.  Inflammatory Bowel Disease and Cerebral Venous Sinus Thrombosis.

Authors:  Sonia S Kupfer; David T Rubin
Journal:  Gastroenterol Hepatol (N Y)       Date:  2006-12

Review 3.  Thromboembolic complications in inflammatory bowel disease.

Authors:  Darina Kohoutova; Paula Moravkova; Peter Kruzliak; Jan Bures
Journal:  J Thromb Thrombolysis       Date:  2015-05       Impact factor: 2.300

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.